AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,674.00p
   
  • Change Today:
    322.00p
  • 52 Week High: 13,276.00p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.67m
  • Volume: 1,942,437
  • Market Cap: £165,519m
  • RiskGrade: 123

Latest ShareCast News

AstraZeneca to invest $50bn in US manufacturing and R&D

By Iain Gilbert

Date: Tuesday 22 Jul 2025

(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that it plans to invest $50.0bn in the US for medicines manufacturing and R&D by 2030.

AstraZeneca ShareCast News

London close: Stocks fall after rise in UK consu... 16-Jul-2025 ShareCast
AstraZeneca drug fails to meet main goal in late... 16-Jul-2025 ShareCast
London close: Stocks rise despite renewed trade ... 14-Jul-2025 ShareCast
Berenberg raises target price on AstraZeneca 09-Jul-2025 ShareCast
Sunday newspaper round-up: Trade, AstraZeneca, T... 06-Jul-2025 ShareCast

AstraZeneca Regulatory News

AstraZeneca plans to invest $50bn in the US 22-Jul-2025 07:00 RNS
Update on anselamimab in AL amyloidosis 16-Jul-2025 07:00 RNS
Baxdrostat met primary endpt in BaxHTN PhIII trial 14-Jul-2025 07:00 RNS
Imfinzi approved in the EU for bladder cancer 04-Jul-2025 07:00 RNS
Total Voting Rights 01-Jul-2025 15:00 RNS

AstraZeneca Newspaper Links

AstraZeneca to invest $50bn in United States 22-Jul-2025 Times
Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail
Some reasons why Pfizer won’t bid for AstraZenec... 19-Nov-2014 Guardian

AstraZeneca Tips & Analysis

Questor :AstraZeneca 29-Apr-2014 Telegraph
Questor : AstraZeneca 24-Jan-2014 Telegraph
Questor:AstraZeneca 22-Dec-2011 Telegraph
Investment Column:AstraZeneca 28-Oct-2011 The Independent
Investment Column: AstraZeneca 23-Jun-2011 The Independent

AstraZeneca News Wires

MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire
CRESTOR Demonstrates Dramatic CV Risk Reduction ... 09-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,674.00p
Change Today 322.00p
% Change 3.11 %
52 Week High 13,276.00p
52 Week Low 9,667.00p
Volume 1,942,437
Shares Issued 1,550.67m
Market Cap £165,519m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.56% below the market average93.56% below the market average93.56% below the market average93.56% below the market average93.56% below the market average
78.26% below the sector average78.26% below the sector average78.26% below the sector average78.26% below the sector average78.26% below the sector average
Price Trend
32.65% below the market average32.65% below the market average32.65% below the market average32.65% below the market average32.65% below the market average
30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average
Income
60.94% below the market average60.94% below the market average60.94% below the market average60.94% below the market average60.94% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
87.44% above the market average87.44% above the market average87.44% above the market average87.44% above the market average87.44% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 23-Jul-2025

Time Volume / Share Price
15:56 0 @ 10,658.00p
15:49 0 @ 10,674.00p
15:49 0 @ 10,674.00p
15:49 0 @ 10,674.00p
15:46 1 @ 10,676.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page